The Immunogenic Potential of Recurrent Cancer Drug Resistance Mutations: An In Silico Study
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Immunogenic Potential of Recurrent Cancer Drug Resistance Mutations: An In Silico Study
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-10-08
DOI
10.3389/fimmu.2020.524968
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical BRCA1/2 reversion analysis identifies hotspot mutations and predicted neoantigens associated with therapy resistance
- (2020) Stephen J. Pettitt et al. Cancer Discovery
- Turning the corner on therapeutic cancer vaccines
- (2019) Robert E. Hollingsworth et al. npj Vaccines
- Cancer Vaccines: Steering T Cells Down the Right Path to Eradicate Tumors
- (2019) Patrick A. Ott et al. Cancer Discovery
- Neoantigen-directed immune escape in lung cancer evolution
- (2019) Rachel Rosenthal et al. NATURE
- Immunogenic neoantigens derived from gene fusions stimulate T cell responses
- (2019) Wei Yang et al. NATURE MEDICINE
- Reduced Neoantigen Expression Revealed by Longitudinal Multiomics as a Possible Immune Evasion Mechanism in Glioma
- (2019) Takahide Nejo et al. Cancer Immunology Research
- How does the immune system learn to distinguish between good and evil? The first definitive studies of T cell central tolerance and positive selection
- (2019) Paweł Kisielow IMMUNOGENETICS
- Next-generation computational tools for interrogating cancer immunity
- (2019) Francesca Finotello et al. NATURE REVIEWS GENETICS
- Pan-cancer whole-genome analyses of metastatic solid tumours
- (2019) Peter Priestley et al. NATURE
- Improved HLA typing of Class I and Class II alleles from next‐generation sequencing data
- (2019) Angelina Sverchkova et al. HLA
- Immunopeptidomics of colorectal cancer organoids reveals a sparse HLA class I neoantigen landscape and no increase in neoantigens with interferon or MEK-inhibitor treatment
- (2019) Alice Newey et al. Journal for ImmunoTherapy of Cancer
- Benchmarking the HLA typing performance of Polysolver and Optitype in 50 Danish parental trios
- (2018) Maria Luisa Matey-Hernandez et al. BMC BIOINFORMATICS
- Membrane protein recycling from the vacuole/lysosome membrane
- (2018) Sho W. Suzuki et al. JOURNAL OF CELL BIOLOGY
- The perfect personalized cancer therapy: cancer vaccines against neoantigens
- (2018) Luigi Aurisicchio et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Past, present, and future of Bcr-Abl inhibitors: from chemical development to clinical efficacy
- (2018) Federico Rossari et al. Journal of Hematology & Oncology
- Next generation of immune checkpoint therapy in cancer: new developments and challenges
- (2018) Julian A. Marin-Acevedo et al. Journal of Hematology & Oncology
- Personalized vaccines for cancer immunotherapy
- (2018) Ugur Sahin et al. SCIENCE
- Challenges towards the realization of individualized cancer vaccines
- (2018) Özlem Türeci et al. Nature Biomedical Engineering
- Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients
- (2018) André Kahles et al. CANCER CELL
- C797S Resistance: The Undruggable EGFR Mutation in Non-Small Cell Lung Cancer?
- (2018) Tobias Grabe et al. ACS Medicinal Chemistry Letters
- Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
- (2018) Spencer C. Wei et al. Cancer Discovery
- Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
- (2018) Derin B. Keskin et al. NATURE
- Noncoding regions are the main source of targetable tumor-specific antigens
- (2018) Céline M. Laumont et al. Science Translational Medicine
- NetMHCpan-4.0: Improved Peptide–MHC Class I Interaction Predictions Integrating Eluted Ligand and Peptide Binding Affinity Data
- (2017) Vanessa Jurtz et al. JOURNAL OF IMMUNOLOGY
- Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis
- (2017) Samra Turajlic et al. LANCET ONCOLOGY
- Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
- (2017) Ugur Sahin et al. NATURE
- An immunogenic personal neoantigen vaccine for patients with melanoma
- (2017) Patrick A. Ott et al. NATURE
- Human Tumor Antigens Yesterday, Today, and Tomorrow
- (2017) Olivera J. Finn Cancer Immunology Research
- Identification of Glycopeptides as Posttranslationally Modified Neoantigens in Leukemia
- (2017) Stacy A. Malaker et al. Cancer Immunology Research
- Transmembrane Helices Are an Overlooked Source of Major Histocompatibility Complex Class I Epitopes
- (2017) Frans Bianchi et al. Frontiers in Immunology
- An Analysis of Natural T Cell Responses to Predicted Tumor Neoepitopes
- (2017) Anne-Mette Bjerregaard et al. Frontiers in Immunology
- Clinical Implications of ESR1 Mutations in Hormone Receptor-Positive Advanced Breast Cancer
- (2017) Tomas Reinert et al. Frontiers in Oncology
- Cancer immunotherapy: the beginning of the end of cancer?
- (2016) Sofia Farkona et al. BMC Medicine
- Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry
- (2016) Michal Bassani-Sternberg et al. Nature Communications
- Personalized Oncology Meets Immunology: The Path toward Precision Immunotherapy
- (2016) R. Mandal et al. Cancer Discovery
- Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non–Small Cell Lung Cancer
- (2016) Valsamo Anagnostou et al. Cancer Discovery
- Tumor neoantigens: building a framework for personalized cancer immunotherapy
- (2015) Matthew M. Gubin et al. JOURNAL OF CLINICAL INVESTIGATION
- Comprehensive analysis of cancer-associated somatic mutations in class I HLA genes
- (2015) Sachet A Shukla et al. NATURE BIOTECHNOLOGY
- Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
- (2015) E. M. Van Allen et al. SCIENCE
- Immunogenicity of somatic mutations in human gastrointestinal cancers
- (2015) E. Tran et al. SCIENCE
- A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells
- (2015) B. M. Carreno et al. SCIENCE
- Human Tumor Antigens and Cancer Immunotherapy
- (2015) Nathalie Vigneron Biomed Research International
- A peptide antigen derived from EGFR T790M is immunogenic in non-small cell lung cancer
- (2014) KAZUYA OFUJI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Drug resistance to targeted therapies: Déjà vu all over again
- (2014) Floris H. Groenendijk et al. Molecular Oncology
- Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing
- (2014) Mahesh Yadav et al. NATURE
- HLA Diversity in the 1000 Genomes Dataset
- (2014) Pierre-Antoine Gourraud et al. PLoS One
- Drug Resistance in Cancer: An Overview
- (2014) Genevieve Housman et al. Cancers
- Cumulative Haploinsufficiency and Triplosensitivity Drive Aneuploidy Patterns and Shape the Cancer Genome
- (2013) Teresa Davoli et al. CELL
- Advances in Androgen Receptor Targeted Therapy for Prostate Cancer
- (2013) Alia Ahmed et al. JOURNAL OF CELLULAR PHYSIOLOGY
- MHC Class I Antigen Processing and Presenting Machinery: Organization, Function, and Defects in Tumor Cells
- (2013) P. Leone et al. JNCI-Journal of the National Cancer Institute
- The Cancer Genome Atlas Pan-Cancer analysis project
- (2013) John N Weinstein et al. NATURE GENETICS
- EGFR T790M Mutation as a Possible Target for Immunotherapy; Identification of HLA-A*0201-Restricted T Cell Epitopes Derived from the EGFR T790M Mutation
- (2013) Teppei Yamada et al. PLoS One
- MHC Class I-Associated Phosphopeptides Are the Targets of Memory-like Immunity in Leukemia
- (2013) M. Cobbold et al. Science Translational Medicine
- Mutated BCR-ABL Generates Immunogenic T-cell Epitopes in CML Patients
- (2012) A. Cai et al. CLINICAL CANCER RESEARCH
- Ponatinib in Refractory Philadelphia Chromosome–Positive Leukemias
- (2012) Jorge E. Cortes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sipuleucel-T (Provenge) autologous vaccine approved for treatment of men with asymptomatic or minimally symptomatic castrate-resistant metastatic prostate cancer
- (2012) Thomas Gardner et al. Human Vaccines & Immunotherapeutics
- Autoimmunity associated with immunotherapy of cancer
- (2011) S. M. Amos et al. BLOOD
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors
- (2011) L. V. Sequist et al. Science Translational Medicine
- Vaccines to Prevent Infections by Oncoviruses
- (2010) John T. Schiller et al. Annual Review of Microbiology
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- EGFR Antagonists in Cancer Treatment
- (2008) Fortunato Ciardiello et al. NEW ENGLAND JOURNAL OF MEDICINE
- About human tumor antigens to be used in immunotherapy
- (2008) S. Lucas et al. SEMINARS IN IMMUNOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started